DRW Securities’s ICU Medical ICUI Stock Holding History

DRW Securities’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-810	Closed	-$204K	–	147
2019 Q2	$204K	Buy	+810	New	+$188K	0.01%	106

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DRW Securities's ICUI Position: Q3 2019 in Review

DRW Securities sold out of ICU Medical (ICUI) in Q3 2019, closing a stake of 810 shares — an estimated $204K sold.

DRW Securities first reported a position in ICUI in Q2 2019 and held it in 1 quarter. The position peaked at $204K in Q2 2019. 260 funds tracked by Wall St. Rank hold ICUI as of Q3 2019.

DRW Securities reported no remaining ICU Medical position as of Q3 2019 after selling out during the quarter.
DRW Securities sold 810 ICU Medical shares in Q3 2019, an estimated $204K.
DRW Securities first reported a position in ICU Medical in Q2 2019 and held it in 1 quarter.
DRW Securities's ICU Medical position peaked at $204K in Q2 2019.
260 funds tracked by Wall St. Rank held ICU Medical as of Q3 2019.

Based on DRW Securities's 13F filing for Q3 2019, filed 14 Nov 2019.